| Style | Citing Format |
|---|---|
| MLA | Haghjooy Javanmard S, et al.. "Neutrophil-To-Lymphocyte Ratio As a Potential Biomarker for Disease Severity in Covid-19 Patients." Journal of Global Antimicrobial Resistance, vol. 22, no. , 2020, pp. 862-863. |
| APA | Haghjooy Javanmard S, Vaseghi G, Manteghinejad A, Nasirian M (2020). Neutrophil-To-Lymphocyte Ratio As a Potential Biomarker for Disease Severity in Covid-19 Patients. Journal of Global Antimicrobial Resistance, 22(), 862-863. |
| Chicago | Haghjooy Javanmard S, Vaseghi G, Manteghinejad A, Nasirian M. "Neutrophil-To-Lymphocyte Ratio As a Potential Biomarker for Disease Severity in Covid-19 Patients." Journal of Global Antimicrobial Resistance 22, no. (2020): 862-863. |
| Harvard | Haghjooy Javanmard S et al. (2020) 'Neutrophil-To-Lymphocyte Ratio As a Potential Biomarker for Disease Severity in Covid-19 Patients', Journal of Global Antimicrobial Resistance, 22(), pp. 862-863. |
| Vancouver | Haghjooy Javanmard S, Vaseghi G, Manteghinejad A, Nasirian M. Neutrophil-To-Lymphocyte Ratio As a Potential Biomarker for Disease Severity in Covid-19 Patients. Journal of Global Antimicrobial Resistance. 2020;22():862-863. |
| BibTex | @article{ author = {Haghjooy Javanmard S and Vaseghi G and Manteghinejad A and Nasirian M}, title = {Neutrophil-To-Lymphocyte Ratio As a Potential Biomarker for Disease Severity in Covid-19 Patients}, journal = {Journal of Global Antimicrobial Resistance}, volume = {22}, number = {}, pages = {862-863}, year = {2020} } |
| RIS | TY - JOUR AU - Haghjooy Javanmard S AU - Vaseghi G AU - Manteghinejad A AU - Nasirian M TI - Neutrophil-To-Lymphocyte Ratio As a Potential Biomarker for Disease Severity in Covid-19 Patients JO - Journal of Global Antimicrobial Resistance VL - 22 IS - SP - 862 EP - 863 PY - 2020 ER - |